The United States Senate is about to consider health system reform legislation which contains a 5% tax on cosmetic surgery deemed unnecessary for medical purposes. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) announces it strongly opposes the inclusion of this tax as it is discriminatory and has already failed in other states. [More]

A new report from the Centers for Medicare and Medicaid Services finds that the health overhaul bill passed by the House will raise health costs by approximately $289 billion in the next ten years. The report was requested by House Republicans and compiled by CMS' chief actuary, Richard Foster. [More]

The Associated Press: "Overall spending on health care would rise as a result of legislation approved a week ago by the House, and billions of dollars in projected savings contained in the measure will be difficult to maintain, according to a report by a top official at the agency that oversees Medicare. [More]

USAction this evening hailed passage of the Affordable Health Care for America Act, which will make health care more affordable for consumers, hold insurance companies accountable and increase access to health care for millions of Americans through a public option. [More]

Smith & Nephew Q3 Results - continued strong profit performance 6 November 2009 Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces its results for the third quarter ended 26 September 2009. [More]

The Affordable Health Care for America Act will make health care more affordable for consumers, hold insurance companies accountable and increase access to health care for millions of Americans. [More]

House Democrats say their health overhaul proposal will lead to health insurance premium savings for many consumers, though estimates of the overall measure's cost, as well as the taxes and fees required to pay for it, is a source of criticism and concern. [More]

It was the usual partisan squabbling on the Sunday talk shows today, while Democrats are braced for a significant week ahead, ironing out significant differences in various health reform bills. [More]

Shire plc, the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009. [More]

Allergan, Inc. today announced operating results for the quarter ended September 30, 2009. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on November 30, 2009 to stockholders of record on November 9, 2009. [More]

WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2009 net income was $730.2 million, or $1.53 per share, including net investment gains of $21.5 million pre-tax, or $0.03 per share, and an impairment charge totaling $205.5 million pre-tax, or $0.28 per share, for certain intangible assets. [More]

Microbix, a developer of a patented technology that doubles the output of influenza vaccine production, announced today it has signed a joint venture agreement with the Hunan Biopharmaceutical Co. Ltd. (a Hunan Province state-owned enterprise) for initial financing to construct Asia's largest influenza vaccine production facility and the third largest vaccine plant in the world. [More]

Medical Marijuana Inc has entered into discussions with a publicly traded coffee distribution company for licensing of its patent pending tax remittance solution. Medical Marijuana Inc's tax remittance technology was originally designed to be industry and product neutral; it can be implemented in any industry. [More]

Pfizer Inc. today reported financial results for third-quarter 2009. Revenues were $11.6 billion, a decrease of 3% compared with $12.0 billion in the year-ago quarter. [More]

Medical Marijuana, Inc. is the ONLY company that provides the specific solutions the government is seeking in order for all collectives and co-ops to be in total compliance with state laws and city/county ordinances. Their revolutionary patent pending Tax Remittance Card and patent pending Inventory Management System and Supply Chain Network provides all of the tools necessary for regulatory authorities and industry operators alike to manage compliance efficiently and effectively. [More]